©The Author(s) 2025.
World J Gastroenterol. Aug 21, 2025; 31(31): 109994
Published online Aug 21, 2025. doi: 10.3748/wjg.v31.i31.109994
Published online Aug 21, 2025. doi: 10.3748/wjg.v31.i31.109994
Table 1 Univariate comparison of preoperative variables between textbook outcome and non-textbook outcome groups
| Characteristic | All (n = 388) | TO achieved (n = 276) | TO not achieved (n = 112) | P value |
| Sex | ||||
| Female | 208 | 156 | 52 | 0.071 |
| Male | 180 | 120 | 60 | |
| Age | 53.5 (18, 84) | 52 (18, 83) | 59 (28, 84) | < 0.01a |
| BMI | 23.66 ± 3.29 | 23.61 ± 3.54 | 23.78 ± 2.59 | 0.607 |
| Admission laboratory tests | ||||
| Platelet count (× 109/L) | 214 (179, 268) | 222 (181, 279) | 209 (176, 247) | 0.166 |
| White blood cell count (× 109/L) | 5.75 (4.75, 7.36) | 5.76 (4.77, 7.35) | 5.68 (4.53, 7.59) | 0.694 |
| Neutrophil count (× 109/L) | 3.30 (2.46, 4.73) | 3.30 (2.46, 4.73) | 3.41 (2.40, 5.43) | 0.294 |
| ALT (U/L) | 71 (20, 228) | 78 (18, 231) | 65 (28, 227) | 0.694 |
| AST (U/L) | 38 (22, 101) | 37 (21, 98) | 40 (25, 140) | 0.162 |
| TB (μmol/L) | 20 (12.6, 40.5) | 18.5 (12.6, 39.3) | 25.6 (12.7, 58) | 0.018a |
| DB (μmol/L) | 10.4 (4.5, 23.6) | 9.5 (4.3, 20.5) | 13.6 (6.2, 46.1) | 0.005a |
| ALP (U/L) | 107.5 (74, 186) | 105 (69, 177) | 117.5 (81, 196) | 0.098 |
| γ-GT (U/L) | 168.5 (41.2, 358.2) | 179.5 (43.5, 368.7) | 168.5 (41.2, 343) | 0.751 |
| Serum amylase (U/L) | 32 (21, 65) | 33 (26, 88) | 29.5 (20, 71.2) | 0.208 |
| Urine amylase (U/L) | 423 (239, 1077) | 451.5 (254, 1111.8) | 376.5 (183, 2028) | 0.295 |
| Fasting blood glucose (mmol/L) | 5.14 (4.66, 6.01) | 5.04 (4.67, 5.88) | 5.59 (4.61, 6.62) | 0.004a |
| Preoperative imaging examinations | ||||
| Common bile duct stone diameter | 0.4 (0.3, 0.6) | 0.3 (0.2, 0.5) | 0.5 (0.3, 0.74) | 0.004a |
| Common bile duct diameter | 0.9 (0.8, 1.1) | 1.0 (0.8, 1.1) | 0.95 (0.8, 1.3) | 0.802 |
| Cystic duct diameter | 0.4 (0.34, 0.5) | 0.4 (0.34, 0.5) | 0.4 (0.34, 0.5) | 0.921 |
| Number of common bile duct stones | 0.257 | |||
| 0 | 62 | 50 | 12 | |
| 1 | 270 | 188 | 82 | |
| 2 | 24 | 18 | 6 | |
| ≥ 3 | 32 | 20 | 12 | |
| Gallbladder wall thickness | 0.370 | |||
| < 3 mm | 194 | 142 | 52 | |
| ≥ 3 mm | 194 | 134 | 60 | |
| Intrahepatic bile duct dilation | 0.303 | |||
| No | 238 | 174 | 64 | |
| Yes | 150 | 102 | 48 | |
| Preoperative diagnoses | < 0.01a | |||
| Cholecystolithiasis | 24 | 12 | 12 | |
| Choledocholithiasis | 322 | 240 | 82 | |
| Biliary pancreatitis | 42 | 24 | 18 | |
| Preoperative interventions | ||||
| Preoperative ERCP | 0.007a | |||
| No | 376 | 272 | 104 | |
| Yes | 12 | 4 | 8 | |
| Preoperative biliary drainage | 0.165 | |||
| No | 356 | 254 | 102 | |
| PTCD | 6 | 6 | 0 | |
| PTGD | 26 | 16 | 10 | |
| Choledochoscope diameter used | 0.408 | |||
| 3 mm | 144 | 106 | 38 | |
| 5 mm | 244 | 170 | 74 | |
| Conversion to open surgery | 0.026a | |||
| No | 386 | 276 | 110 | |
| Yes | 2 | 0 | 2 | |
| Anesthesia time | 106 (85, 137) | 102 (82, 125) | 125 (90, 170) | < 0.001a |
| ASA score | 0.032a | |||
| 1 | 32 | 24 | 8 | |
| 2 | 316 | 230 | 86 | |
| 3 | 38 | 22 | 16 | |
| 4 | 2 | 0 | 2 | |
| Hypertension | 0.095 | |||
| No | 286 | 210 | 76 | |
| Yes | 102 | 66 | 36 | |
| Diabetes | 0.88 | |||
| No | 352 | 250 | 112 | |
| Yes | 36 | 26 | 10 | |
| Coronary heart disease | 0.004a | |||
| No | 362 | 264 | 98 | |
| Yes | 26 | 12 | 14 |
- Citation: Zhu DS, Zhang Z, Huang XR, Zhang JZ, Zhang ZW, Guo XY, Zheng H, Guo T, Yu YH. Textbook outcome and associated risk factors in laparoscopic transcystic common bile duct exploration. World J Gastroenterol 2025; 31(31): 109994
- URL: https://www.wjgnet.com/1007-9327/full/v31/i31/109994.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i31.109994